Home Page for immunose
Skip to content
  • What It Is
  • How It Works
  • Who’s Using It
  • Demo
  • Pricing
  • Knowledge Center
  • Client Login

Knowledge Center

Customer Support

Frequently Asked Questions
Sample
Preparation
Shipping Instructions
SEQing Answers Blog
Instructions Metadata Wizard
Assistance with Grant Applications
Quick Reference Guide

Understanding immunoSEQ

Video
Tutorials
Webinar
Series
Therapeautic Areas of Interest
Press
Releases
Case Study: Reproducibility
Case Study:
MRD

The Science Behind immunoSEQ

Adaptive Scientific Publications
Basic
Immunology
How TCRs
Work
Next Generation Sequen. Assays

    SEQing Answers Blog

    Providing guidance, insights, and Q&As to help researchers use the immunoSEQ platform.

    Read Blog»

    Knowledge Center

    To understand better the technology and science behind immunoSEQ.

    • Basic immunology overview
    • Adaptive scientific publications
    • Sign up for training webinar
    • Case Study: Reproducibility
    • Case Study: Minimal Residual Disease
    • Frequently Asked Questions
    • Video Tutorials

    Knowledge Center»

    Latest Press Releases

    • New Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More Sensitive than Traditional Method to Detect Minimal Residual Disease in Leukemia
    • Adaptive Biotechnologies Hires Leading High-Throughput Sequencing Expert, Dr. Mark Rieder, as Senior Vice President of Operations
    • Adaptive TCR changes name to Adaptive Biotechnologies.

    Press Releases»

  • immunoSEQ Overview

    ImmunoSEQ Demo
immunoSEQ is a product of
Copyright © 2012 Adaptive Biotechnologies Corporation. All rights reserved. Site by Microsite.com.